IRIS Accounts Production v24.1.4.33 09668795 director 1.10.22 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh096687952022-09-30096687952024-03-31096687952022-10-012024-03-31096687952021-09-30096687952021-10-012022-09-30096687952022-09-3009668795ns15:EnglandWales2022-10-012024-03-3109668795ns14:PoundSterling2022-10-012024-03-3109668795ns10:Director12022-10-012024-03-3109668795ns10:PrivateLimitedCompanyLtd2022-10-012024-03-3109668795ns10:SmallEntities2022-10-012024-03-3109668795ns10:AuditExempt-NoAccountantsReport2022-10-012024-03-3109668795ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012024-03-3109668795ns10:SmallCompaniesRegimeForAccounts2022-10-012024-03-3109668795ns10:FullAccounts2022-10-012024-03-3109668795ns10:RegisteredOffice2022-10-012024-03-3109668795ns5:CurrentFinancialInstruments2024-03-3109668795ns5:CurrentFinancialInstruments2022-09-3009668795ns5:ShareCapital2024-03-3109668795ns5:ShareCapital2022-09-3009668795ns5:RetainedEarningsAccumulatedLosses2024-03-3109668795ns5:RetainedEarningsAccumulatedLosses2022-09-3009668795ns5:PlantMachinery2022-10-012024-03-3109668795ns5:PlantMachinery2022-09-3009668795ns5:PlantMachinery2024-03-3109668795ns5:PlantMachinery2022-09-3009668795ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3109668795ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-3009668795ns5:DeferredTaxation2022-09-3009668795ns5:DeferredTaxation2022-10-012024-03-3109668795ns5:DeferredTaxation2024-03-31
REGISTERED NUMBER: 09668795 (England and Wales)



















Unaudited Financial Statements

for the Period 1 October 2022 to 31 March 2024

for

A Davies Laboratories Ltd

A Davies Laboratories Ltd (Registered number: 09668795)

Contents of the Financial Statements
for the Period 1 October 2022 to 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A Davies Laboratories Ltd

Company Information
for the Period 1 October 2022 to 31 March 2024







DIRECTOR: A W Davies





REGISTERED OFFICE: Unit 3d Canal Bridge
Byfleet Road
New Haw
Addlestone
Surrey
KT15 3JE





REGISTERED NUMBER: 09668795 (England and Wales)





ACCOUNTANTS: APT
44 The Pantiles
Tunbridge Wells
Kent
TN2 5TN

A Davies Laboratories Ltd (Registered number: 09668795)

Balance Sheet
31 March 2024

31.3.24 30.9.22
Notes £    £   
FIXED ASSETS
Tangible assets 4 27,329 617
Investments 5 128,421 -
155,750 617

CURRENT ASSETS
Debtors 6 36,836 59,000
Cash at bank 84,882 8,329
121,718 67,329
CREDITORS
Amounts falling due within one year 7 (55,653 ) (25,554 )
NET CURRENT ASSETS 66,065 41,775
TOTAL ASSETS LESS CURRENT
LIABILITIES

221,815

42,392

PROVISIONS FOR LIABILITIES 8 (4,327 ) (154 )
NET ASSETS 217,488 42,238

CAPITAL AND RESERVES
Called up share capital 2 1
Retained earnings 217,486 42,237
SHAREHOLDERS' FUNDS 217,488 42,238

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A Davies Laboratories Ltd (Registered number: 09668795)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 July 2024 and were signed by:





A W Davies - Director


A Davies Laboratories Ltd (Registered number: 09668795)

Notes to the Financial Statements
for the Period 1 October 2022 to 31 March 2024


1. STATUTORY INFORMATION

A Davies Laboratories Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The functional and presentational currency of the company is pounds sterling. Monetary amounts in these financial statements are rounded to the nearest £1, except where otherwise indicated.

Going concern
After reviewing the company's forecasts and projections, the members have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Significant judgements and estimates
Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Debtors and creditors receivable/payable in one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


A Davies Laboratories Ltd (Registered number: 09668795)

Notes to the Financial Statements - continued
for the Period 1 October 2022 to 31 March 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Provision for liabilities
Provisions are recognised when the company has a present obligation (legal or constructive) as a result of a past event, it is probable that the company will be required to settle the obligation, and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the end of the reporting period, taking into account the risks and uncertainties surrounding the obligation.

Dividends
Dividends are recognised as liabilities once they are no longer at the discretion of the company.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2022 - 1 ) .

A Davies Laboratories Ltd (Registered number: 09668795)

Notes to the Financial Statements - continued
for the Period 1 October 2022 to 31 March 2024


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2022 16,027
Additions 28,481
Disposals (4,067 )
At 31 March 2024 40,441
DEPRECIATION
At 1 October 2022 15,410
Charge for period 1,769
Eliminated on disposal (4,067 )
At 31 March 2024 13,112
NET BOOK VALUE
At 31 March 2024 27,329
At 30 September 2022 617

5. FIXED ASSET INVESTMENTS

Investments (neither listed nor unlisted) were as follows:
31.3.24 30.9.22
£    £   
Capital introduced 128,421 -

Fixed Asset Investments (neither listed nor unlisted) represents the company's capital account balance in a Limited Liability Partnership.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 30.9.22
£    £   
Trade debtors 31,806 -
Other debtors 5,030 59,000
36,836 59,000

A Davies Laboratories Ltd (Registered number: 09668795)

Notes to the Financial Statements - continued
for the Period 1 October 2022 to 31 March 2024


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 30.9.22
£    £   
Trade creditors 5,988 63
Taxation and social security 46,665 10,906
Other creditors 3,000 14,585
55,653 25,554

8. PROVISIONS FOR LIABILITIES
31.3.24 30.9.22
£    £   
Deferred tax 4,327 154

Deferred
tax
£   
Balance at 1 October 2022 154
Charge to Statement of Income and Retained Earnings during period 4,173
Balance at 31 March 2024 4,327

9. RELATED PARTY DISCLOSURES

As at 31 March 2024 £nil (2022: £13,335) was owed to an entity controlled by key management personnel.

During the period under review, fees of £227,500 (2022: £59,000) were charged to an entity controlled by key management personnel.

On 31 March 2024 the trade and assets of a connected entity were transferred into the company.